Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1098/RSOB.160255 | ||||
| Año | 2016 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
The von Hippel-Lindau (VHL) protein serves to recruit the hypoxia-inducible factor alpha (HIF1a) protein under normoxia to the CUL2 E3 ubiquitin ligase for its ubiquitylation and degradation through the proteasome. In this report, we modify VHL to engineer an affinity-directed protein missile (AdPROM) system to direct specific endogenous target proteins for proteolysis in mammalian cells. The proteolytic AdPROM construct harbours a cameloid anti-green fluorescence protein (aGFP) nanobody that is fused to VHL for either constitutive or tetracycline-inducible expression. For target proteins, we exploit CRISPR/Cas9 to rapidly generate human kidney HEK293 and U2OS osteosarcoma homozygous knock-in cells harbouring GFP tags at the VPS34 (vacuolar protein sorting 34) and protein associated with SMAD1 (PAWS1, aka FAM83G) loci, respectively. Using these cells, we demonstrate that the expression of the VHL-aGFP AdPROMsystem results in near-complete degradation of the endogenous GFP-VPS34 and PAWS1-GFP proteins through the proteasome. Additionally, we show that Tet-inducible destruction of GFP-VPS34 results in the degradation of its associated partner, UVRAG, and reduction in levels of cellular phosphatidylinositol 3-phosphate.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Fulcher, Luke J. | Hombre |
Univ Dundee - Reino Unido
Universidad Austral de Chile - Chile |
| 2 | Macartney, Thomas | Hombre |
Univ Dundee - Reino Unido
Universidad Austral de Chile - Chile |
| 3 | Bozatzi, Polyxeni | Mujer |
Univ Dundee - Reino Unido
Universidad Austral de Chile - Chile |
| 4 | Hornberger, Annika | Mujer |
Univ Dundee - Reino Unido
Universidad Austral de Chile - Chile |
| 5 | ROJAS-FERNANDEZ, ALEJANDRO ALFREDO | Hombre |
Universidad Austral de Chile - Chile
|
| 6 | Sapkota, Gopal P. | Hombre |
Univ Dundee - Reino Unido
Universidad Austral de Chile - Chile |
| Fuente |
|---|
| Medical Research Council |
| GlaxoSmithKline |
| UK Medical Research Council |
| Boehringer-Ingelheim |
| Pfizer |
| AstraZeneca |
| Janssen |
| Merck-Serono |
| UK MRC Prize PhD studentships |
| Center for Interdisciplinary Studies on the Nervous System and Institute of Medicine, Universidad Austral de Chile |
| Agradecimiento |
|---|
| This study was funded by the UK Medical Research Council (grant number MC_UU_12016/3). L.J.F. and P.B. are supported by the UK MRC Prize PhD studentships. G.P.S. is supported by the UK Medical Research Council and the pharmaceutical companies supporting the DSTT (AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck-Serono, Pfizer and Janssen). |